Aurinia Pharmaceuticals Ownership 2024 | Who Owns Aurinia Pharmaceuticals Now?
Institutional Ownership
38.29%
Insider Ownership
7.07%
Retail Ownership
54.63%
Institutional Holders
177.00
Aurinia Pharmaceuticals Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 7.73% | 0.80% | 11,136,000 | -1,124,000 | -9.17% | 63,586,560 | Jun 30, 2024 |
| BLACKROCK INC. | 6.44% | 0.00% | 9,272,162 | 609,184 | 7.03% | 52,944,046 | Jun 30, 2024 |
| NEA MANAGEMENT COMPANY, LLC | 2.76% | 1.71% | 3,969,834 | - | - | 22,667,752 | Jun 30, 2024 |
| STATE STREET CORP | 2.00% | 0.00% | 2,880,111 | 109,247 | 3.94% | 16,445,434,000 | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 1.93% | 1.62% | 2,779,500 | 729,500 | 35.59% | 15,870,945 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 1.57% | 0.00% | 2,254,657 | 102,503 | 4.76% | 12,874,092 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 1.25% | 0.00% | 1,803,430 | -255,677 | -12.42% | 10,297,585 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.22% | 0.00% | 1,763,602 | 160,522 | 10.01% | 10,070,166 | Jun 30, 2024 |
| VANGUARD GROUP INC | 1.07% | 0.00% | 1,539,112 | 7,495 | 0.49% | 8,788,329 | Jun 30, 2024 |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 0.82% | 0.20% | 1,179,740 | 29,393 | 2.56% | 6,736,315 | Jun 30, 2024 |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 0.69% | 0.01% | 997,221 | -43,309 | -4.16% | 5,694,132 | Jun 30, 2024 |
| MORGAN STANLEY | 0.69% | 0.00% | 987,876 | -316,262 | -24.25% | 5,640,774 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.68% | 0.00% | 979,984 | -42,808 | -4.19% | 5,595,709,000 | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.45% | 0.00% | 654,110 | 115,152 | 21.37% | 3,734,968 | Jun 30, 2024 |
| WOODLINE PARTNERS LP | 0.43% | 0.03% | 614,066 | 113,511 | 22.68% | 3,506,317 | Jun 30, 2024 |
| SEGALL BRYANT & HAMILL, LLC | 0.38% | 0.06% | 553,744 | 553,744 | 100.00% | 3,161,878 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 0.35% | 0.00% | 507,034 | 199,103 | 64.66% | 2,895,165 | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | 0.34% | 0.00% | 488,721 | 77,510 | 18.85% | 2,790,597 | Jun 30, 2024 |
| STATE OF WISCONSIN INVESTMENT BOARD | 0.29% | 0.01% | 416,928 | -19,954 | -4.57% | 2,380,659 | Jun 30, 2024 |
| 683 CAPITAL MANAGEMENT, LLC | 0.28% | 0.17% | 400,000 | -215,000 | -34.96% | 2,284,000 | Jun 30, 2024 |
Aurinia Pharmaceuticals's largest institutional shareholder is ARMISTICE CAPITAL, LLC, holding 7.73% of the company's total share outstanding, currently valued at $63.59M. The top 10 institutional shareholders own together 26.79% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| NEA MANAGEMENT COMPANY, LLC | 2.76% | 1.71% | 3,969,834 | - | - | 22,667,752 | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 1.93% | 1.62% | 2,779,500 | 729,500 | 35.59% | 15,870,945 | Jun 30, 2024 |
| STONEPINE CAPITAL MANAGEMENT, LLC | 0.21% | 1.57% | 300,000 | 300,000 | 100.00% | 1,713,000 | Jun 30, 2024 |
| ARMISTICE CAPITAL, LLC | 7.73% | 0.80% | 11,136,000 | -1,124,000 | -9.17% | 63,586,560 | Jun 30, 2024 |
| VIRTUS INVESTMENT ADVISERS, INC. | 0.06% | 0.40% | 82,828 | 82,828 | 100.00% | 472,948 | Jun 30, 2024 |
| ALPHACENTRIC ADVISORS LLC | 0.06% | 0.34% | 80,000 | - | - | 456,800 | Jun 30, 2024 |
| HIGHMARK WEALTH MANAGEMENT LLC | 0.06% | 0.31% | 91,196 | 16,000 | 21.28% | 520,729 | Jun 30, 2024 |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 0.06% | 0.27% | 89,862 | -3,317 | -3.56% | 513,112 | Jun 30, 2024 |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 0.82% | 0.20% | 1,179,740 | 29,393 | 2.56% | 6,736,315 | Jun 30, 2024 |
| 683 CAPITAL MANAGEMENT, LLC | 0.28% | 0.17% | 400,000 | -215,000 | -34.96% | 2,284,000 | Jun 30, 2024 |
| VIRTUS ETF ADVISERS LLC | 0.04% | 0.17% | 61,561 | 19,366 | 45.90% | 351,513 | Jun 30, 2024 |
| VIRTUS FUND ADVISERS, LLC | 0.00% | 0.15% | 6,788 | 6,788 | 100.00% | 38,759 | Jun 30, 2024 |
| SUNBELT SECURITIES, INC. | 0.11% | 0.09% | 160,225 | -25,050 | -13.52% | 914,885 | Jun 30, 2024 |
| PDT PARTNERS, LLC | 0.12% | 0.09% | 171,349 | 171,349 | 100.00% | 978,403 | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | 0.16% | 0.09% | 228,018 | -121,186 | -34.70% | 1,302,000 | Jun 30, 2024 |
| SEGALL BRYANT & HAMILL, LLC | 0.38% | 0.06% | 553,744 | 553,744 | 100.00% | 3,161,878 | Jun 30, 2024 |
| PATTEN & PATTEN INC/TN | 0.06% | 0.04% | 92,544 | 15,429 | 20.01% | 528,426 | Jun 30, 2024 |
| ALGERT GLOBAL LLC | 0.13% | 0.04% | 193,804 | 100,104 | 106.83% | 1,107,000 | Jun 30, 2024 |
| BCS WEALTH MANAGEMENT | 0.01% | 0.03% | 12,170 | - | - | 69,000 | Jun 30, 2024 |
| WOODLINE PARTNERS LP | 0.43% | 0.03% | 614,066 | 113,511 | 22.68% | 3,506,317 | Jun 30, 2024 |
The largest Aurinia Pharmaceuticals shareholder by % of total assets is NEA MANAGEMENT COMPANY, LLC. The company owns 3.97M shares of Aurinia Pharmaceuticals (AUPH), representing 1.71% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 1.93% | 1.62% | 2,779,500 | 729,500 | 35.59% | 15,870,945 | Jun 30, 2024 |
| BLACKROCK INC. | 6.44% | 0.00% | 9,272,162 | 609,184 | 7.03% | 52,944,046 | Jun 30, 2024 |
| SEGALL BRYANT & HAMILL, LLC | 0.38% | 0.06% | 553,744 | 553,744 | 100.00% | 3,161,878 | Jun 30, 2024 |
| STONEPINE CAPITAL MANAGEMENT, LLC | 0.21% | 1.57% | 300,000 | 300,000 | 100.00% | 1,713,000 | Jun 30, 2024 |
| AQR CAPITAL MANAGEMENT LLC | 0.14% | 0.00% | 202,241 | 202,241 | 100.00% | 1,154,796 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 0.35% | 0.00% | 507,034 | 199,103 | 64.66% | 2,895,165 | Jun 30, 2024 |
| PDT PARTNERS, LLC | 0.12% | 0.09% | 171,349 | 171,349 | 100.00% | 978,403 | Jun 30, 2024 |
| UBS ASSET MANAGEMENT AMERICAS INC | 0.23% | 0.00% | 325,882 | 165,734 | 103.49% | 1,860,786 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.22% | 0.00% | 1,763,602 | 160,522 | 10.01% | 10,070,166 | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.45% | 0.00% | 654,110 | 115,152 | 21.37% | 3,734,968 | Jun 30, 2024 |
| NORGES BANK | 0.08% | 0.00% | 114,045 | 114,045 | 100.00% | 651,197 | Jun 30, 2024 |
| WOODLINE PARTNERS LP | 0.43% | 0.03% | 614,066 | 113,511 | 22.68% | 3,506,317 | Jun 30, 2024 |
| STATE STREET CORP | 2.00% | 0.00% | 2,880,111 | 109,247 | 3.94% | 16,445,434,000 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 1.57% | 0.00% | 2,254,657 | 102,503 | 4.76% | 12,874,092 | Jun 30, 2024 |
| ALGERT GLOBAL LLC | 0.13% | 0.04% | 193,804 | 100,104 | 106.83% | 1,107,000 | Jun 30, 2024 |
| VIRTUS INVESTMENT ADVISERS, INC. | 0.06% | 0.40% | 82,828 | 82,828 | 100.00% | 472,948 | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | 0.34% | 0.00% | 488,721 | 77,510 | 18.85% | 2,790,597 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.05% | 0.00% | 77,240 | 77,240 | 100.00% | 441,040 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.05% | 0.00% | 68,334 | 68,334 | 100.00% | 390,187 | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | 0.04% | 0.01% | 60,000 | 60,000 | 100.00% | 342,600 | Jun 30, 2024 |
As of Jun 30 2024, Aurinia Pharmaceuticals's largest institutional buyer is TANG CAPITAL MANAGEMENT LLC. The company purchased 729.50K stocks of AUPH, valued at $15.87M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 7.73% | 0.80% | 11,136,000 | -1,124,000 | -9.17% | 63,586,560 | Jun 30, 2024 |
| GROUP ONE TRADING, L.P. | - | - | - | -377,322 | -100.00% | - | Jun 30, 2024 |
| MORGAN STANLEY | 0.69% | 0.00% | 987,876 | -316,262 | -24.25% | 5,640,774 | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | - | - | - | -288,875 | -100.00% | - | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 1.25% | 0.00% | 1,803,430 | -255,677 | -12.42% | 10,297,585 | Jun 30, 2024 |
| LEVEL FOUR ADVISORY SERVICES, LLC | - | - | - | -236,800 | -100.00% | - | Jun 30, 2024 |
| CAMPBELL & CO INVESTMENT ADVISER LLC | 0.01% | 0.01% | 19,597 | -217,498 | -91.73% | 111,899 | Jun 30, 2024 |
| 683 CAPITAL MANAGEMENT, LLC | 0.28% | 0.17% | 400,000 | -215,000 | -34.96% | 2,284,000 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | - | -172,153 | -100.00% | - | Jun 30, 2024 |
| GTS SECURITIES LLC | 0.07% | 0.00% | 95,700 | -151,500 | -61.29% | 546,447 | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | 0.16% | 0.09% | 228,018 | -121,186 | -34.70% | 1,302,000 | Jun 30, 2024 |
| SUPERSTRING CAPITAL MANAGEMENT LP | - | - | - | -98,691 | -100.00% | - | Jun 30, 2024 |
| BARCLAYS PLC | 0.05% | 0.00% | 76,259 | -96,465 | -55.85% | 435,000 | Jun 30, 2024 |
| GTS SECURITIES LLC | 0.02% | 0.00% | 32,224 | -93,047 | -74.28% | 183,999 | Jun 30, 2024 |
| JUPITER ASSET MANAGEMENT LTD | 0.11% | 0.01% | 158,497 | -88,555 | -35.84% | 905,018 | Jun 30, 2024 |
| WOLVERINE TRADING, LLC | - | - | - | -79,700 | -100.00% | - | Jun 30, 2024 |
| HENNION & WALSH ASSET MANAGEMENT, INC. | - | - | - | -75,787 | -100.00% | - | Jun 30, 2024 |
| HSBC HOLDINGS PLC | 0.01% | 0.00% | 14,553 | -68,498 | -82.48% | 81,788 | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -66,738 | -100.00% | - | Jun 30, 2024 |
| BNP PARIBAS ARBITRAGE, SNC | 0.01% | 0.00% | 11,754 | -66,712 | -85.02% | 67,115 | Jun 30, 2024 |
As of Jun 30 2024, Aurinia Pharmaceuticals's biggest institutional seller is ARMISTICE CAPITAL, LLC. The company sold -1.12M shares of AUPH, valued at $63.59M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| SEGALL BRYANT & HAMILL, LLC | 0.38% | 0.06% | 553,744 | 553,744 | 100.00% | 3,161,878 | Jun 30, 2024 |
| STONEPINE CAPITAL MANAGEMENT, LLC | 0.21% | 1.57% | 300,000 | 300,000 | 100.00% | 1,713,000 | Jun 30, 2024 |
| PDT PARTNERS, LLC | 0.12% | 0.09% | 171,349 | 171,349 | 100.00% | 978,403 | Jun 30, 2024 |
| NORGES BANK | 0.08% | 0.00% | 114,045 | 114,045 | 100.00% | 651,197 | Jun 30, 2024 |
| VIRTUS INVESTMENT ADVISERS, INC. | 0.06% | 0.40% | 82,828 | 82,828 | 100.00% | 472,948 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.05% | 0.00% | 77,240 | 77,240 | 100.00% | 441,040 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.05% | 0.00% | 68,334 | 68,334 | 100.00% | 390,187 | Jun 30, 2024 |
| GOTHAM ASSET MANAGEMENT, LLC | 0.03% | 0.00% | 40,292 | 40,292 | 100.00% | 230,067 | Jun 30, 2024 |
| J. SAFRA SARASIN HOLDING AG | 0.02% | 0.00% | 25,500 | 25,500 | 100.00% | 145,605 | Jun 30, 2024 |
| VERITION FUND MANAGEMENT LLC | 0.01% | 0.00% | 18,935 | 18,935 | 100.00% | 108,119 | Jun 30, 2024 |
| AMERIPRISE FINANCIAL INC | 0.01% | - | 10,685 | 10,685 | 100.00% | 61,012 | Jun 30, 2024 |
| VIRTUS FUND ADVISERS, LLC | 0.00% | 0.15% | 6,788 | 6,788 | 100.00% | 38,759 | Jun 30, 2024 |
| ACTIVEST WEALTH MANAGEMENT | 0.00% | 0.01% | 3,000 | 3,000 | 100.00% | 17,130 | Jun 30, 2024 |
| OPTIVER HOLDING B.V. | 0.00% | - | 1,785 | 1,785 | 100.00% | 10,192 | Jun 30, 2024 |
| JONES FINANCIAL COMPANIES LLLP | 0.00% | - | 700 | 700 | 100.00% | 3,997 | Jun 30, 2024 |
| SIGNATUREFD, LLC | 0.00% | - | 179 | 179 | 100.00% | 1,022 | Jun 30, 2024 |
| ROTHSCHILD INVESTMENT LLC | 0.00% | - | 75 | 75 | 100.00% | 428 | Jun 30, 2024 |
Aurinia Pharmaceuticals's largest new institutional shareholder by number of shares is SEGALL BRYANT & HAMILL, LLC, purchased 553.74K shares, valued at $3.16M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| GROUP ONE TRADING, L.P. | - | - | - | -377,322 | -100.00% | - | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | - | - | - | -288,875 | -100.00% | - | Jun 30, 2024 |
| LEVEL FOUR ADVISORY SERVICES, LLC | - | - | - | -236,800 | -100.00% | - | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | - | -172,153 | -100.00% | - | Jun 30, 2024 |
| SUPERSTRING CAPITAL MANAGEMENT LP | - | - | - | -98,691 | -100.00% | - | Jun 30, 2024 |
| WOLVERINE TRADING, LLC | - | - | - | -79,700 | -100.00% | - | Jun 30, 2024 |
| HENNION & WALSH ASSET MANAGEMENT, INC. | - | - | - | -75,787 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -66,738 | -100.00% | - | Jun 30, 2024 |
| CANTOR FITZGERALD, L. P. | - | - | - | -54,033 | -100.00% | - | Jun 30, 2024 |
| NATIXIS | - | - | - | -50,717 | -100.00% | - | Jun 30, 2024 |
| BARCLAYS PLC | - | - | - | -42,500 | -100.00% | - | Jun 30, 2024 |
| FLPUTNAM INVESTMENT MANAGEMENT CO | - | - | - | -40,391 | -100.00% | - | Jun 30, 2024 |
| CAPSTONE INVESTMENT ADVISORS, LLC | - | - | - | -31,458 | -100.00% | - | Jun 30, 2024 |
| ATOM INVESTORS LP | - | - | - | -30,658 | -100.00% | - | Jun 30, 2024 |
| XTX TOPCO LTD | - | - | - | -23,491 | -100.00% | - | Jun 30, 2024 |
| SHERBROOKE PARK ADVISERS LLC | - | - | - | -23,017 | -100.00% | - | Jun 30, 2024 |
| QUANTBOT TECHNOLOGIES LP | - | - | - | -20,500 | -100.00% | - | Jun 30, 2024 |
| WALLEYE CAPITAL LLC | - | - | - | -17,700 | -100.00% | - | Jun 30, 2024 |
| DYNAMIC TECHNOLOGY LAB PRIVATE LTD | - | - | - | -17,444 | -100.00% | - | Jun 30, 2024 |
| TUDOR INVESTMENT CORP ET AL | - | - | - | -14,954 | -100.00% | - | Jun 30, 2024 |
| COASTAL INVESTMENT ADVISORS, INC. | - | - | - | -13,738 | -100.00% | - | Jun 30, 2024 |
| COMMONWEALTH EQUITY SERVICES, LLC | - | - | - | -11,307 | -100.00% | - | Jun 30, 2024 |
| GREAT VALLEY ADVISOR GROUP, INC. | - | - | - | -10,400 | -100.00% | - | Jun 30, 2024 |
| BRIDGEFRONT CAPITAL, LLC | - | - | - | -10,279 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -7,999 | -100.00% | - | Jun 30, 2024 |
| DEKABANK DEUTSCHE GIROZENTRALE | - | - | - | -7,480 | -100.00% | - | Jun 30, 2024 |
| BELVEDERE TRADING LLC | - | - | - | -4,497 | -100.00% | - | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | - | - | - | -2,000 | -100.00% | - | Jun 30, 2024 |
| RESOURCES MANAGEMENT CORP /CT/ /ADV | - | - | - | -1,000 | -100.00% | - | Jun 30, 2024 |
| PACIFICA PARTNERS INC. | - | - | - | -1,000 | -100.00% | - | Jun 30, 2024 |
| TRUVESTMENTS CAPITAL LLC | - | - | - | -687 | -100.00% | - | Jun 30, 2024 |
| LOWE WEALTH ADVISORS, LLC | - | - | - | -531 | -100.00% | - | Jun 30, 2024 |
| WALLEYE TRADING LLC | - | - | - | -300 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -26 | -100.00% | - | Jun 30, 2024 |
| VIMA LLC | - | - | - | -25 | -100.00% | - | Jun 30, 2024 |
Aurinia Pharmaceuticals's largest sold out institutional shareholder by shares sold is GROUP ONE TRADING, L.P., sold -0.38M shares, valued at -, as of undefined.
Aurinia Pharmaceuticals Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| ALGER FUNDS | 0.33% | 321,659 | - | - | Jan 31, 2024 |
| Gabelli Healthcare & WellnessRx Trust | 0.33% | 40,000 | - | - | Dec 29, 2023 |
| ALGER FUNDS II | 0.26% | 59,615 | - | - | Jan 31, 2024 |
| GABELLI ASSET FUND | 0.18% | 65,000 | - | - | Dec 29, 2023 |
| Gabelli Global Small & Mid Cap Value Trust | 0.16% | 15,000 | - | - | Dec 29, 2023 |
| FRANKLIN STRATEGIC SERIES | 0.13% | 1,073,800 | - | - | Jan 31, 2024 |
| TEKLA LIFE SCIENCES INVESTORS | 0.12% | 58,380 | - | - | Mar 31, 2024 |
| TEKLA HEALTHCARE INVESTORS | 0.12% | 104,219 | - | - | Mar 31, 2024 |
| FIDELITY ADVISOR SERIES VII | 0.11% | 918,700 | - | - | Jan 31, 2024 |
| GABELLI DIVIDEND & INCOME TRUST | 0.09% | 160,000 | - | - | Dec 29, 2023 |
| VELA Funds | 0.08% | 26,530 | - | - | Dec 31, 2023 |
| QUANTITATIVE MASTER SERIES LLC | 0.04% | 239,076 | -6,583 | -2.68% | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.03% | 19,755 | -974 | -4.70% | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND III | 0.03% | 235,500 | - | - | Mar 31, 2024 |
| ETFis Series Trust I | 0.03% | 36,124 | 5,267 | 17.07% | Jan 31, 2024 |
| FIDELITY CAPITAL TRUST | 0.02% | 193,295 | - | - | Jan 31, 2024 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.02% | 71,044 | - | - | Mar 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.02% | 3,648 | - | - | Mar 31, 2024 |
| VALUED ADVISERS TRUST | 0.01% | 12,102 | - | - | Jan 31, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.01% | 40,515 | 651 | 1.63% | Feb 29, 2024 |
| FIDELITY SECURITIES FUND | 0.01% | 1,122,900 | - | - | Jan 31, 2024 |
| FIDELITY ADVISOR SERIES I | 0.01% | 2,207,653 | - | - | Feb 29, 2024 |
| LORD ABBETT SECURITIES TRUST | 0.01% | 55,514 | - | - | Jan 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.01% | 481,922 | 43,888 | 10.02% | Jan 31, 2024 |
| AMG Funds IV | 0.01% | 31,356 | - | - | Jan 31, 2024 |
| ALPS ETF Trust | 0.01% | 108,578 | 7,271 | 7.18% | Feb 29, 2024 |
| TIAA-CREF LIFE FUNDS | 0.01% | 20,040 | 809 | 4.21% | Mar 31, 2024 |
| VANGUARD QUANTITATIVE FUNDS | 0.01% | 28,200 | - | - | Mar 31, 2024 |
| Federated Hermes Equity Funds | 0.01% | 111,446 | - | - | Jan 31, 2024 |
| Ultimus Managers Trust | 0.01% | 58,488 | - | - | Feb 29, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 13,454 | - | - | Mar 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.00% | 255,886 | - | - | Feb 29, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 70,173 | -1,125 | -1.58% | Jan 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 66,134 | 11,810 | 21.74% | Mar 31, 2024 |
| VANGUARD WORLD FUND | 0.00% | 492,621 | 5,695 | 1.17% | Feb 29, 2024 |
| Weiss Strategic Interval Fund | 0.00% | 5,209 | 5,209 | - | Sep 30, 2022 |
| Virtus Investment Trust | 0.00% | 49,318 | - | - | Mar 28, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 17,062 | -1,988 | -10.44% | Mar 31, 2024 |
| Fidelity Commonwealth Trust II | 0.00% | 9,128 | - | - | Aug 31, 2023 |
| Global X Funds | 0.00% | 60,419 | - | - | Jan 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 6,359 | -383 | -5.68% | Mar 31, 2024 |
| DIAMOND HILL FUNDS | 0.00% | 55,079 | 26,505 | 92.76% | Dec 31, 2023 |
| Fidelity Central Investment Portfolios LLC | 0.00% | 59,000 | - | - | Feb 29, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 147,711 | - | - | Mar 31, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 918,603 | -196,600 | -17.63% | Mar 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 48,700 | 3,600 | 7.98% | Mar 31, 2024 |
| SPDR INDEX SHARES FUNDS | 0.00% | 146,620 | 56,587 | 62.85% | Mar 31, 2024 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.00% | 54,579 | 54 | 0.10% | Jan 31, 2024 |
| DEUTSCHE DWS SECURITIES TRUST | 0.00% | 20,198 | - | - | Jan 31, 2024 |
| PRUDENTIAL INVESTMENT PORTFOLIOS, INC. | 0.00% | 5,300 | - | - | Mar 28, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 5,153 | - | - | Mar 31, 2024 |
| TIAA-CREF FUNDS | 0.00% | 1,264,194 | 67,321 | 5.62% | Jan 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 83,656 | 1,917 | 2.35% | Feb 29, 2024 |
| NORTHERN FUNDS | 0.00% | 56,895 | -1,404 | -2.41% | Mar 28, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 8,773 | 959 | 12.27% | Mar 31, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 90,758 | - | - | Jan 31, 2024 |
| iSHARES TRUST | 0.00% | 5,468,159 | -330,919 | -5.71% | Mar 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 622,228 | 76,744 | 14.07% | Feb 29, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 1,235 | - | - | Dec 31, 2023 |
| EQ ADVISORS TRUST | 0.00% | 342,711 | -4,864 | -1.40% | Mar 31, 2024 |
| CLEARWATER INVESTMENT TRUST | 0.00% | 2,390 | 2,390 | - | Mar 28, 2024 |
| VICTORY PORTFOLIOS | 0.00% | 6,904 | - | - | Mar 31, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 24,807 | - | - | Feb 29, 2024 |
| J.P. Morgan Exchange-Traded Fund Trust | 0.00% | 82,746 | 3,868 | 4.90% | Jan 31, 2024 |
| VALIC Co I | 0.00% | 51,969 | -210 | -0.40% | Feb 29, 2024 |
| GOLDMAN SACHS TRUST | 0.00% | 628,536 | 25,148 | 4.17% | Jan 31, 2024 |
| FLEXSHARES TRUST | 0.00% | 13,114 | -316 | -2.35% | Jan 31, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 4,500 | - | - | Mar 28, 2024 |
| Victory Portfolios II | 0.00% | 7,833 | - | - | Mar 31, 2024 |
| Goldman Sachs ETF Trust | 0.00% | 14,909 | 5,282 | 54.87% | Feb 29, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 613 | - | - | Dec 31, 2023 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 18,492 | - | - | Jan 31, 2024 |
| PROSHARES TRUST | 0.00% | 30,572 | 3,925 | 14.73% | Feb 29, 2024 |
| Fidelity Rutland Square Trust II | 0.00% | 133,660 | - | - | Feb 29, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 6,612 | - | - | Feb 29, 2024 |
| VANGUARD WELLINGTON FUND | 0.00% | 40,485 | - | - | Feb 29, 2024 |
| ProFunds | 0.00% | 1,052 | -88 | -7.72% | Mar 31, 2024 |
| Series Portfolios Trust | 0.00% | 475 | - | - | Jan 31, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 177,391 | - | - | Mar 31, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 81 | - | - | Dec 31, 2023 |
| HC CAPITAL TRUST | 0.00% | 1,790 | - | - | Mar 31, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 5,607 | 826 | 17.28% | Feb 29, 2024 |
| Brighthouse Funds Trust II | 0.00% | 46,041 | - | - | Mar 31, 2024 |
| Blackstone Alternative Investment Funds | 0.00% | 6,100 | - | - | Mar 31, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 18,380 | -93 | -0.50% | Jan 31, 2024 |
| Brinker Capital Destinations Trust | 0.00% | 2,417 | - | - | Feb 29, 2024 |
| VANGUARD INTERNATIONAL EQUITY INDEX FUNDS | 0.00% | 77,558 | -10,823 | -12.25% | Jan 31, 2024 |
| Invesco Exchange-Traded Self-Indexed Fund Trust | 0.00% | 8,184 | - | - | Feb 29, 2024 |
| ETF Series Solutions | 0.00% | 698 | - | - | Jan 31, 2024 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 2,769 | - | - | Mar 31, 2024 |
| ADVANCED SERIES TRUST | 0.00% | 94,100 | - | - | Mar 28, 2024 |
| VANGUARD STAR FUNDS | 0.00% | 45,087 | - | - | Jan 31, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 47,939 | -1,645 | -3.32% | Mar 31, 2024 |
| SEI INSTITUTIONAL MANAGED TRUST | 0.00% | 56,315 | -18,850 | -25.08% | Dec 31, 2023 |
| MUTUAL FUND SERIES TRUST | 0.00% | 80,000 | 30,000 | 60.00% | Mar 31, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 68,212 | 9,128 | 15.45% | Mar 31, 2024 |
| RUSSELL INVESTMENT FUNDS | 0.00% | 1,914 | - | - | Mar 31, 2024 |
| Bridge Builder Trust | 0.00% | 59,566 | 34,509 | 137.72% | Mar 31, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 3,810 | 1,308 | 52.28% | Feb 29, 2024 |
| PACIFIC SELECT FUND | 0.00% | 43,511 | -994 | -2.23% | Mar 31, 2024 |
Aurinia Pharmaceuticals's largest mutual fund holder by % of total assets is "ALGER FUNDS", owning 321.66K shares, compromising 0.33% of its total assets.
Aurinia Pharmaceuticals Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 177 | -10.15% |
| 31 Mar, 24 | 197 | -6.19% |
| 31 Dec, 23 | 210 | -2.78% |
| 30 Sep, 23 | 216 | -1.37% |
| 30 Jun, 23 | 219 | 8.42% |
| 31 Mar, 23 | 202 | -4.27% |
| 31 Dec, 22 | 211 | 3.43% |
| 30 Sep, 22 | 204 | -3.77% |
| 30 Jun, 22 | 212 | - |
| 31 Mar, 22 | 212 | -3.20% |
| 31 Dec, 21 | 219 | 11.73% |
| 30 Sep, 21 | 196 | 6.52% |
| 30 Jun, 21 | 184 | 1.10% |
| 31 Mar, 21 | 182 | 14.47% |
| 31 Dec, 20 | 159 | -0.63% |
| 30 Sep, 20 | 160 | 11.11% |
| 30 Jun, 20 | 144 | 4.35% |
| 31 Mar, 20 | 138 | 0.73% |
| 31 Dec, 19 | 137 | 71.25% |
| 30 Sep, 19 | 80 | - |
| 30 Jun, 19 | 80 | -5.88% |
| 31 Mar, 19 | 85 | 32.81% |
| 31 Dec, 18 | 64 | -5.88% |
| 30 Sep, 18 | 68 | -8.11% |
| 30 Jun, 18 | 74 | 7.25% |
| 31 Mar, 18 | 69 | -10.39% |
| 31 Dec, 17 | 77 | 4.05% |
| 30 Sep, 17 | 74 | -6.33% |
| 30 Jun, 17 | 79 | -9.20% |
| 31 Mar, 17 | 87 | 222.22% |
| 31 Dec, 16 | 27 | 92.86% |
| 30 Sep, 16 | 14 | 7.69% |
| 30 Jun, 16 | 13 | -18.75% |
| 31 Mar, 16 | 16 | 14.29% |
| 31 Dec, 15 | 14 | 27.27% |
| 30 Sep, 15 | 11 | -15.38% |
| 30 Jun, 15 | 13 | 18.18% |
| 31 Mar, 15 | 11 | 10.00% |
| 31 Dec, 14 | 10 | 11.11% |
| 30 Sep, 14 | 9 | - |
As of 30 Jun 24, 177 institutions are holding Aurinia Pharmaceuticals's shares, representing a decrease of -10.15% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 55,147,655 | 0.34% |
| 31 Mar, 24 | 54,961,177 | 3.27% |
| 31 Dec, 23 | 53,221,003 | 5.95% |
| 30 Sep, 23 | 50,234,131 | 0.83% |
| 30 Jun, 23 | 49,820,958 | -0.35% |
| 31 Mar, 23 | 49,995,337 | -2.17% |
| 31 Dec, 22 | 51,103,962 | -7.57% |
| 30 Sep, 22 | 55,290,646 | 10.44% |
| 30 Jun, 22 | 50,062,796 | 17.65% |
| 31 Mar, 22 | 42,553,401 | 10.13% |
| 31 Dec, 21 | 38,639,243 | -11.18% |
| 30 Sep, 21 | 43,500,997 | -11.36% |
| 30 Jun, 21 | 49,075,444 | -5.87% |
| 31 Mar, 21 | 52,136,993 | -10.11% |
| 31 Dec, 20 | 58,003,584 | -10.48% |
| 30 Sep, 20 | 64,793,684 | 10.64% |
| 30 Jun, 20 | 58,563,086 | -2.78% |
| 31 Mar, 20 | 60,238,957 | 23.36% |
| 31 Dec, 19 | 48,832,465 | 91.70% |
| 30 Sep, 19 | 25,473,980 | -13.20% |
| 30 Jun, 19 | 29,346,559 | -1.60% |
| 31 Mar, 19 | 29,822,839 | 34.29% |
| 31 Dec, 18 | 22,207,771 | 3.31% |
| 30 Sep, 18 | 21,495,247 | 1.02% |
| 30 Jun, 18 | 21,277,660 | -2.02% |
| 31 Mar, 18 | 21,716,478 | -9.35% |
| 31 Dec, 17 | 23,956,148 | 1.43% |
| 30 Sep, 17 | 23,617,469 | 1.85% |
| 30 Jun, 17 | 23,187,654 | -2.86% |
| 31 Mar, 17 | 23,870,451 | 176.66% |
| 31 Dec, 16 | 8,628,072 | 103.58% |
| 30 Sep, 16 | 4,238,270 | -40.06% |
| 30 Jun, 16 | 7,070,693 | 4.85% |
| 31 Mar, 16 | 6,743,499 | 0.16% |
| 31 Dec, 15 | 6,732,993 | -5.31% |
| 30 Sep, 15 | 7,110,273 | -1.55% |
| 30 Jun, 15 | 7,222,390 | -5.07% |
| 31 Mar, 15 | 7,607,904 | -10.33% |
| 31 Dec, 14 | 8,484,581 | 41.02% |
| 30 Sep, 14 | 6,016,777 | - |
Aurinia Pharmaceuticals (AUPH) has 55.15M shares outstanding as of 30 Jun 24, up 0.34% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 38.29% | 2.60% |
| 31 Mar, 24 | 38.37% | 2.78% |
| 31 Dec, 23 | 37.16% | 3.00% |
| 30 Sep, 23 | 35.18% | 2.88% |
| 30 Jun, 23 | 34.93% | 2.84% |
| 31 Mar, 23 | 35.05% | 2.70% |
| 31 Dec, 22 | 36.01% | 2.37% |
| 30 Sep, 22 | 38.98% | 3.12% |
| 30 Jun, 22 | 35.32% | 3.92% |
| 31 Mar, 22 | 30.04% | 3.37% |
| 31 Dec, 21 | 29.87% | 2.60% |
| 30 Sep, 21 | 33.87% | 2.31% |
| 30 Jun, 21 | 38.27% | 2.29% |
| 31 Mar, 21 | 40.92% | 1.71% |
| 31 Dec, 20 | 48.96% | 1.75% |
| 30 Sep, 20 | 52.95% | 1.96% |
| 30 Jun, 20 | 52.02% | 1.80% |
| 31 Mar, 20 | 53.68% | 2.16% |
| 31 Dec, 19 | 49.86% | 6.53% |
| 30 Sep, 19 | 27.64% | 2.70% |
| 30 Jun, 19 | 31.98% | 2.92% |
| 31 Mar, 19 | 33.08% | 4.89% |
| 31 Dec, 18 | 26.01% | 4.10% |
| 30 Sep, 18 | 25.19% | 3.96% |
| 30 Jun, 18 | 25.23% | 3.78% |
| 31 Mar, 18 | 25.84% | 3.12% |
| 31 Dec, 17 | 28.76% | 3.60% |
| 30 Sep, 17 | 28.25% | 3.62% |
| 30 Jun, 17 | 27.95% | 1.58% |
| 31 Mar, 17 | 42.11% | 18.17% |
| 31 Dec, 16 | 15.22% | 11.03% |
| 30 Sep, 16 | 11.75% | 2.49% |
| 30 Jun, 16 | 21.72% | 4.98% |
| 31 Mar, 16 | 20.89% | 4.76% |
| 31 Dec, 15 | 20.94% | 4.32% |
| 30 Sep, 15 | 22.03% | 4.39% |
| 30 Jun, 15 | 22.40% | 3.93% |
| 31 Mar, 15 | 23.88% | 3.37% |
| 31 Dec, 14 | 26.63% | 7.31% |
| 30 Sep, 14 | 19.09% | - |
As of 30 Jun 24, Aurinia Pharmaceuticals is held by 38.29% institutional shareholders, representing a 2.60% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 83 | 10.67% |
| 31 Mar, 24 | 75 | -9.64% |
| 31 Dec, 23 | 83 | -10.75% |
| 30 Sep, 23 | 93 | -2.11% |
| 30 Jun, 23 | 95 | -2.06% |
| 31 Mar, 23 | 97 | 7.78% |
| 31 Dec, 22 | 90 | 18.42% |
| 30 Sep, 22 | 76 | -20.00% |
| 30 Jun, 22 | 95 | -11.21% |
| 31 Mar, 22 | 107 | -1.83% |
| 31 Dec, 21 | 109 | 28.24% |
| 30 Sep, 21 | 85 | -5.56% |
| 30 Jun, 21 | 90 | -8.16% |
| 31 Mar, 21 | 98 | 28.95% |
| 31 Dec, 20 | 76 | -22.45% |
| 30 Sep, 20 | 98 | 40.00% |
| 30 Jun, 20 | 70 | 2.94% |
| 31 Mar, 20 | 68 | -17.07% |
| 31 Dec, 19 | 82 | 156.25% |
| 30 Sep, 19 | 32 | 23.08% |
| 30 Jun, 19 | 26 | -35.00% |
| 31 Mar, 19 | 40 | 100.00% |
| 31 Dec, 18 | 20 | -28.57% |
| 30 Sep, 18 | 28 | -6.67% |
| 30 Jun, 18 | 30 | 15.38% |
| 31 Mar, 18 | 26 | -31.58% |
| 31 Dec, 17 | 38 | 26.67% |
| 30 Sep, 17 | 30 | -21.05% |
| 30 Jun, 17 | 38 | -42.42% |
| 31 Mar, 17 | 66 | 266.67% |
| 31 Dec, 16 | 18 | 80.00% |
| 30 Sep, 16 | 10 | 100.00% |
| 30 Jun, 16 | 5 | - |
| 31 Mar, 16 | 5 | -37.50% |
| 31 Dec, 15 | 8 | 100.00% |
| 30 Sep, 15 | 4 | -42.86% |
| 30 Jun, 15 | 7 | 75.00% |
| 31 Mar, 15 | 4 | - |
| 31 Dec, 14 | 4 | -55.56% |
| 30 Sep, 14 | 9 | - |
83 institutional shareholders have increased their position in AUPH stock as of 30 Jun 24 compared to 75 in the previous quarter (a 10.67% increase).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 41 | -33.87% |
| 31 Mar, 24 | 62 | 1.64% |
| 31 Dec, 23 | 61 | 22.00% |
| 30 Sep, 23 | 50 | -9.09% |
| 30 Jun, 23 | 55 | 19.57% |
| 31 Mar, 23 | 46 | -2.13% |
| 31 Dec, 22 | 47 | -11.32% |
| 30 Sep, 22 | 53 | 12.77% |
| 30 Jun, 22 | 47 | 6.82% |
| 31 Mar, 22 | 44 | -25.42% |
| 31 Dec, 21 | 59 | 11.32% |
| 30 Sep, 21 | 53 | 26.19% |
| 30 Jun, 21 | 42 | -10.64% |
| 31 Mar, 21 | 47 | 17.50% |
| 31 Dec, 20 | 40 | 37.93% |
| 30 Sep, 20 | 29 | -14.71% |
| 30 Jun, 20 | 34 | 6.25% |
| 31 Mar, 20 | 32 | 52.38% |
| 31 Dec, 19 | 21 | 23.53% |
| 30 Sep, 19 | 17 | -32.00% |
| 30 Jun, 19 | 25 | 25.00% |
| 31 Mar, 19 | 20 | - |
| 31 Dec, 18 | 20 | 66.67% |
| 30 Sep, 18 | 12 | -25.00% |
| 30 Jun, 18 | 16 | -15.79% |
| 31 Mar, 18 | 19 | 18.75% |
| 31 Dec, 17 | 16 | 6.67% |
| 30 Sep, 17 | 15 | -21.05% |
| 30 Jun, 17 | 19 | 280.00% |
| 31 Mar, 17 | 5 | 66.67% |
| 31 Dec, 16 | 3 | 200.00% |
| 30 Sep, 16 | 1 | -66.67% |
| 30 Jun, 16 | 3 | -50.00% |
| 31 Mar, 16 | 6 | 500.00% |
| 31 Dec, 15 | 1 | -66.67% |
| 30 Sep, 15 | 3 | 50.00% |
| 30 Jun, 15 | 2 | -50.00% |
| 31 Mar, 15 | 4 | 100.00% |
| 31 Dec, 14 | 2 | - |
| 30 Sep, 14 | - | - |
41 institutional shareholders have reduced their position in AUPH stock as of 30 Jun 24 compared to 62 in the previous quarter (a -33.87% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 177 | -10.15% | 55,147,655 | 0.34% | 38.29% | 2.60% | 83 | 10.67% | 41 | -33.87% |
| 31 Mar, 24 | 197 | -6.19% | 54,961,177 | 3.27% | 38.37% | 2.78% | 75 | -9.64% | 62 | 1.64% |
| 31 Dec, 23 | 210 | -2.78% | 53,221,003 | 5.95% | 37.16% | 3.00% | 83 | -10.75% | 61 | 22.00% |
| 30 Sep, 23 | 216 | -1.37% | 50,234,131 | 0.83% | 35.18% | 2.88% | 93 | -2.11% | 50 | -9.09% |
| 30 Jun, 23 | 219 | 8.42% | 49,820,958 | -0.35% | 34.93% | 2.84% | 95 | -2.06% | 55 | 19.57% |
| 31 Mar, 23 | 202 | -4.27% | 49,995,337 | -2.17% | 35.05% | 2.70% | 97 | 7.78% | 46 | -2.13% |
| 31 Dec, 22 | 211 | 3.43% | 51,103,962 | -7.57% | 36.01% | 2.37% | 90 | 18.42% | 47 | -11.32% |
| 30 Sep, 22 | 204 | -3.77% | 55,290,646 | 10.44% | 38.98% | 3.12% | 76 | -20.00% | 53 | 12.77% |
| 30 Jun, 22 | 212 | - | 50,062,796 | 17.65% | 35.32% | 3.92% | 95 | -11.21% | 47 | 6.82% |
| 31 Mar, 22 | 212 | -3.20% | 42,553,401 | 10.13% | 30.04% | 3.37% | 107 | -1.83% | 44 | -25.42% |
| 31 Dec, 21 | 219 | 11.73% | 38,639,243 | -11.18% | 29.87% | 2.60% | 109 | 28.24% | 59 | 11.32% |
| 30 Sep, 21 | 196 | 6.52% | 43,500,997 | -11.36% | 33.87% | 2.31% | 85 | -5.56% | 53 | 26.19% |
| 30 Jun, 21 | 184 | 1.10% | 49,075,444 | -5.87% | 38.27% | 2.29% | 90 | -8.16% | 42 | -10.64% |
| 31 Mar, 21 | 182 | 14.47% | 52,136,993 | -10.11% | 40.92% | 1.71% | 98 | 28.95% | 47 | 17.50% |
| 31 Dec, 20 | 159 | -0.63% | 58,003,584 | -10.48% | 48.96% | 1.75% | 76 | -22.45% | 40 | 37.93% |
| 30 Sep, 20 | 160 | 11.11% | 64,793,684 | 10.64% | 52.95% | 1.96% | 98 | 40.00% | 29 | -14.71% |
| 30 Jun, 20 | 144 | 4.35% | 58,563,086 | -2.78% | 52.02% | 1.80% | 70 | 2.94% | 34 | 6.25% |
| 31 Mar, 20 | 138 | 0.73% | 60,238,957 | 23.36% | 53.68% | 2.16% | 68 | -17.07% | 32 | 52.38% |
| 31 Dec, 19 | 137 | 71.25% | 48,832,465 | 91.70% | 49.86% | 6.53% | 82 | 156.25% | 21 | 23.53% |
| 30 Sep, 19 | 80 | - | 25,473,980 | -13.20% | 27.64% | 2.70% | 32 | 23.08% | 17 | -32.00% |
| 30 Jun, 19 | 80 | -5.88% | 29,346,559 | -1.60% | 31.98% | 2.92% | 26 | -35.00% | 25 | 25.00% |
| 31 Mar, 19 | 85 | 32.81% | 29,822,839 | 34.29% | 33.08% | 4.89% | 40 | 100.00% | 20 | - |
| 31 Dec, 18 | 64 | -5.88% | 22,207,771 | 3.31% | 26.01% | 4.10% | 20 | -28.57% | 20 | 66.67% |
| 30 Sep, 18 | 68 | -8.11% | 21,495,247 | 1.02% | 25.19% | 3.96% | 28 | -6.67% | 12 | -25.00% |
| 30 Jun, 18 | 74 | 7.25% | 21,277,660 | -2.02% | 25.23% | 3.78% | 30 | 15.38% | 16 | -15.79% |
| 31 Mar, 18 | 69 | -10.39% | 21,716,478 | -9.35% | 25.84% | 3.12% | 26 | -31.58% | 19 | 18.75% |
| 31 Dec, 17 | 77 | 4.05% | 23,956,148 | 1.43% | 28.76% | 3.60% | 38 | 26.67% | 16 | 6.67% |
| 30 Sep, 17 | 74 | -6.33% | 23,617,469 | 1.85% | 28.25% | 3.62% | 30 | -21.05% | 15 | -21.05% |
| 30 Jun, 17 | 79 | -9.20% | 23,187,654 | -2.86% | 27.95% | 1.58% | 38 | -42.42% | 19 | 280.00% |
| 31 Mar, 17 | 87 | 222.22% | 23,870,451 | 176.66% | 42.11% | 18.17% | 66 | 266.67% | 5 | 66.67% |
| 31 Dec, 16 | 27 | 92.86% | 8,628,072 | 103.58% | 15.22% | 11.03% | 18 | 80.00% | 3 | 200.00% |
| 30 Sep, 16 | 14 | 7.69% | 4,238,270 | -40.06% | 11.75% | 2.49% | 10 | 100.00% | 1 | -66.67% |
| 30 Jun, 16 | 13 | -18.75% | 7,070,693 | 4.85% | 21.72% | 4.98% | 5 | - | 3 | -50.00% |
| 31 Mar, 16 | 16 | 14.29% | 6,743,499 | 0.16% | 20.89% | 4.76% | 5 | -37.50% | 6 | 500.00% |
| 31 Dec, 15 | 14 | 27.27% | 6,732,993 | -5.31% | 20.94% | 4.32% | 8 | 100.00% | 1 | -66.67% |
| 30 Sep, 15 | 11 | -15.38% | 7,110,273 | -1.55% | 22.03% | 4.39% | 4 | -42.86% | 3 | 50.00% |
| 30 Jun, 15 | 13 | 18.18% | 7,222,390 | -5.07% | 22.40% | 3.93% | 7 | 75.00% | 2 | -50.00% |
| 31 Mar, 15 | 11 | 10.00% | 7,607,904 | -10.33% | 23.88% | 3.37% | 4 | - | 4 | 100.00% |
| 31 Dec, 14 | 10 | 11.11% | 8,484,581 | 41.02% | 26.63% | 7.31% | 4 | -55.56% | 2 | - |
| 30 Sep, 14 | 9 | - | 6,016,777 | - | 19.09% | - | 9 | - | - | - |
Aurinia Pharmaceuticals Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Aurinia Pharmaceuticals's stock was made by Habig Scott Michael on Aug 08 2024, selling 18,249 shares at $5.31 per share (valued at $96.90K).
Aurinia Pharmaceuticals Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | 1 | - |
| Q2 2024 | - | 5 | - |
| Q1 2024 | 5 | 8 | 62.50% |
| Q3 2023 | 6 | - | - |
| Q2 2023 | 17 | 12 | 141.67% |
| Q1 2023 | 8 | 6 | 133.33% |
| Q4 2022 | 3 | - | - |
| Q3 2022 | 4 | - | - |
| Q2 2022 | 12 | 1 | 1200.00% |
| Q1 2022 | 18 | 10 | 180.00% |
| Q4 2021 | 7 | 19 | 36.84% |
| Q3 2021 | 11 | 31 | 35.48% |
| Q2 2021 | 19 | 3 | 633.33% |
| Q1 2021 | 8 | 78 | 10.26% |
0 total buy trades, and 1 total sell trades (buy/sell ratio of 0.00%) were made by Aurinia Pharmaceuticals's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | 1 | - |
| Q2 2024 | - | 5 | - |
| Q1 2024 | - | 8 | - |
| Q3 2023 | - | - | - |
| Q2 2023 | - | 5 | - |
| Q1 2023 | 1 | 6 | 16.67% |
| Q4 2022 | 3 | - | - |
| Q3 2022 | - | - | - |
| Q2 2022 | - | - | - |
| Q1 2022 | 2 | 9 | 22.22% |
| Q4 2021 | 1 | 12 | 8.33% |
| Q3 2021 | - | 20 | - |
| Q2 2021 | 9 | 1 | 900.00% |
| Q1 2021 | 4 | 1 | 400.00% |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 1 open market sell trades of Aurinia Pharmaceuticals's stocks.
Aurinia Pharmaceuticals Peer Ownership
| Ticker | Company |
|---|---|
| AKRO | Akero Therapeutics, Inc. |
| TGTX | TG Therapeutics, Inc. |
| PTCT | PTC Therapeutics, Inc. |
| BTAI | BioXcel Therapeutics, Inc. |
| EXEL | Exelixis, Inc. |
| SRPT | Sarepta Therapeutics, Inc. |
| MCRB | Seres Therapeutics, Inc. |
| TERN | Terns Pharmaceuticals, Inc. |
| VKTX | Viking Therapeutics, Inc. |
| AXSM | Axsome Therapeutics, Inc. |
| HEPA | Hepion Pharmaceuticals, Inc. |
| MDGL | Madrigal Pharmaceuticals, Inc. |
AUPH Ownership FAQ
Who Owns Aurinia Pharmaceuticals?
Aurinia Pharmaceuticals is owned by institutional shareholders (38.29%), insiders (7.07%), and public (54.63%). The largest institutional shareholder of Aurinia Pharmaceuticals is ARMISTICE CAPITAL, LLC (7.73% of total shares) and the top mutual fund owner is ALGER FUNDS (0.33% of total shares).
Who are the major institutional shareholders of Aurinia Pharmaceuticals?
Aurinia Pharmaceuticals's major institutional shareholders are ARMISTICE CAPITAL, LLC, BLACKROCK INC., NEA MANAGEMENT COMPANY, LLC, STATE STREET CORP, and TANG CAPITAL MANAGEMENT LLC. The top five shareholders own together 20.86% of the company's share outstanding.
How many Aurinia Pharmaceuticals shareholders are there?
As of Jun 2024, there are 177 institutional shareholders of Aurinia Pharmaceuticals.
What percentage of Aurinia Pharmaceuticals is owned by ARMISTICE CAPITAL, LLC?
ARMISTICE CAPITAL, LLC owns 11.14M shares of Aurinia Pharmaceuticals, representing 7.73% of the company's total shares outstanding, valued at $63.59M (as of Jun 2024).
What percentage of Aurinia Pharmaceuticals is owned by BLACKROCK INC?
As of Jun 2024, BLACKROCK INC holds 9.27M shares of Aurinia Pharmaceuticals (AUPH), compromising 6.44% of the company, valued at $52.94M.
What percentage of Aurinia Pharmaceuticals is owned by NEA MANAGEMENT COMPANY, LLC?
NEA MANAGEMENT COMPANY, LLC is the third largest holder of Aurinia Pharmaceuticals. The company owns 3.97M of the company's shares outstanding (worth $22.67M).